ACP5 and breast carcinoma: Consistently, silencing HDAC1 in the breast cancer cells significantly abolished the reductive effect of NKX2-8 on the formation of TRAP+-multinuclear osteoclasts and TRAP enzymatic activity (Figures 6A, B).